Bharat Parenterals Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,334 shares, with a market capitalization of ₹6891963. Its Average Traded Price (ATP) is ₹1465.01, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1472.40.
Bharat Parenterals has an upper circuit limit of ₹1729.40 and a lower circuit limit of ₹1153.00. The total value traded stands at ₹19.54 L, and the delivery percentage for the day is 68.25%.
The stock is currently traded with a market lot size of 1. Bharat Parenterals also offers a dividend yield of 0.07%.
Bharat Parenterals share price chart
Bharat Parenterals Share Key Metrics
Volume
1334.00
Market Cap
1014.77 CR
LTQ@LTP
5@1472.40
ATP
1465.01
Var Margin
25 %
Circuit Range
1153-1729.4
Delivery %
68.25 %
Value
19.54 L
ASM/GSM
No
Market Lot
1
Bharat Parenterals Resistance and Support
Pivot 1452.73
Resistance
First Resistance
1476.46
Second Resistance
1511.73
Third Resistance
1535.46
Support
First Support
1417.46
Second Support
1393.73
Third Support
1358.46
Bharat Parenterals Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Bharat Parenterals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results & A.G.M. |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-28 | Quarterly Results & A.G.M. |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| 2026-08-05 | Quarterly Results & A.G.M. |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-28 | Quarterly Results & A.G.M. |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-19 | 2025-09-19 | View More |
Bharat Parenterals News
Bharat Parenterals Ltd - 541096 - Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.
Bharat Parenterals' equity shares have been admitted for trading on the National Stock Exchange (NSE) with effect from August 17, 2026. This move is expected to improve the company's market visibility and liquidity for investors.
Aug 20 2026 12:38:34
Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Bharat Parenterals' wholly-owned subsidiary, Varenyam Biolifesciences, is upgrading its Savli manufacturing facility to include biologics and biosimilar CDMO capabilities. The Phase 1 capital expenditure has been revised to Rs.300 crore, up from Rs.150 crore, targeting regulated markets like the US and EU by Q2 2028.
Aug 11 2026 15:39:26
Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of Board Meeting
Bharat Parenterals reported Q1 FY27 cons. revenue of ₹93.74 cr, down 19.2% YoY, with a net loss of ₹3.56 cr. The board also approved the 33rd AGM for September 19, 2026, and re-appointed Mr. Hemang Shah as Executive Director for 5 years.
Aug 05 2026 17:40:07
Bharat Parenterals Management
| Name | Position |
|---|---|
| Sharmin Soni | Company Secretary & Compliance Officer |
| Bharat Desai | Chairman & Managing Director |
Bharat Parenterals Similar Stocks
Anuh Pharma Ltd.
77.27
-1.56 (1.98%)
Kopran Ltd.
192.50
-1.38 (0.71%)
Themis Medicare Ltd.
119.24
-1.57 (1.30%)
Wanbury Ltd.
264.35
-2.90 (1.09%)
Hexagon Nutrition Ltd.
69.81
-0.67 (0.95%)
Gaudium IVF and Women Health Ltd.
115.90
2.27 (2.00%)
Albert David Ltd.
867.95
-20.75 (2.33%)
Anlon Healthcare Ltd.
15.05
-0.38 (2.46%)
Bharat Parenterals FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BPLPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC